A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Trial details
- Registry ID
- NCT05032040
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesNCT05032040 | XNCR | Phase 2 | Active not recruiting | 2025-10-15Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |